TREA

79350047 - AITEM

Follow

Information

  • Trademark
  • 79350047
  • Serial Number
    79350047
  • Registration Number
    7369448
  • Filing Date
    July 15, 2022
    3 years ago
  • Registration Date
    April 30, 2024
    a year ago
  • Transaction Date
    December 07, 2024
    11 months ago
  • Status Date
    April 30, 2024
    a year ago
  • Published for Opposition Date
    February 13, 2024
    a year ago
  • Location Date
    April 29, 2024
    a year ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    MATZINGER, AMY
  • Attorney Docket Number
    LIU-54671
    Attorney Name
    MARK E. BANDY
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AITEM
Case File Statements
  • GS0051: Medicines for human purposes, namely, for use for central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Chemico-pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Capsules being medicines, namely, capsules for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney related diseases, gastrointestinal diseases; Sedatives; Vaccines; Drugs for medical purposes, namely, central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Medicines in tablet form, namely, medicinal preparations for the mouth to be applied in the form of tablets; Injectable medicinal solutions, namely, powder for injection, parenteral solutions, solutions for injection, intravenous injections, suspensions for injection, sterile powders for injection, intravenous injections, emulsion for injection, emulsion injections, powder injections, and concentrated solutions for injection, all for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pain relief medication; Immunostimulants; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of viral diseases; Medicinal preparations for the treatment of musculoskeletal disorders; Drugs and preparations for the treatment of gastrointestinal diseases; Medicinal preparations for skin diseases
  • GS0421: Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Pharmaceutical research; Scientific research and development; Conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Computer hardware design; Research and development of new products for others; Providing computer software design for others; Electronic data storage; Conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; Conversion of data or documents from physical to electronic media; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; Computer programming
Case File Event Statements
  • 5/18/2023 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/16/2022 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 9/20/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/24/2022 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/2/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/17/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/22/2023 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/23/2023 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/22/2023 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNP
  • 12/8/2023 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/19/2023 - a year ago
    10 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/8/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/8/2023 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/4/2024 - a year ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/4/2024 - a year ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/4/2024 - a year ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/4/2024 - a year ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/10/2024 - a year ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/24/2024 - a year ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/24/2024 - a year ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/29/2024 - a year ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/13/2024 - a year ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/13/2024 - a year ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/26/2024 - a year ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/19/2024 - a year ago
    24 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/21/2024 - a year ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 4/30/2024 - a year ago
    30 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/30/2024 - a year ago
    29 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/26/2024 - a year ago
    32 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 3/17/2024 - a year ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 4/30/2024 - a year ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/30/2024 - a year ago
    31 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/7/2024 - 11 months ago
    34 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/27/2024 - a year ago
    33 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS